Nalini S. Bora

High Impact

Professor

UAMS primary UA Little Rock University of Arkansas

Also affiliated: Howard Hughes Medical Institute (1988–1992); University of Louisville (2001–2006); Duke University (1990); Washington University in St. Louis (1989–1998); University of Arkansas Medical Center (2016); Yale University (2003); Arkansas Cardiology (2007–2011); Central Arkansas Veterans Healthcare System (2012); Mallinckrodt (United States) (2003); Jones Institute (2006–2011); Minnesota Lions Eye Bank (2004); Osaka International Cancer Institute (1988); Arkansas Department of Agriculture (2014–2015); Walker (United States) (2008); Saint Louis University (1994); All India Institute of Medical Sciences (2013); Jewish Hospital (1991)

Faculty Researcher

33 h-index 167 pubs 3,485 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website Research Group

OverviewAI-generated summary

Nalini S. Bora is a professor at the University of Arkansas for Medical Sciences whose research focuses on understanding and developing treatments for retinal diseases, particularly age-related macular degeneration (AMD) and related conditions. Her work investigates the molecular mechanisms underlying these diseases, with recent publications exploring the role of adiponectin and its signaling pathways in choroidal neovascularization, diabetic retinopathy, and AMD. Bora also studies the synthesis of novel compounds for treating inflammatory conditions affecting the eye.

Her research group has published extensively on topics related to retinal cell degeneration and employs animal models to study disease progression. Key collaborators include Valeriy V. Lyzogubov, Connor Logan, and Reece Mitchell, with whom she has co-authored multiple publications. Bora's scholarship metrics include an h-index of 33, with over 3,400 citations across 167 publications, reflecting her significant contributions to the field. She is recognized as a highly cited researcher.

Metrics

h-index: 33
Publications: 167
Citations: 3,485

Selected Publications

Role of Adiponectin in the Treatment of Age-Related Macular Degeneration and Other Metabolic Disorders (2024)

DOI OpenAlex
Age-Related Macular Degeneration Models Induced by Polyethylene Glycol (PEG) (2024)

DOI OpenAlex
Role of Complement in the Ocular Immune Response (2024)

Elsevier eBooks DOI OpenAlex
Therapeutic Advancement of Adiponectin in Age-Related Macular Degeneration and Other Metabolic Disorders. (2024)

Preprints.org 1 citation DOI OpenAlex
Genetic Insights into Age-Related Macular Degeneration (2024)

Biomedicines 24 citations DOI OpenAlex
Pivotal Roles of APN/AdipoRs Signaling in Maintaining Ocular Homeostasis and Protecting against Eye Ailments (2024)

DOI OpenAlex
Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD) (2023)

Biomedicines 5 citations DOI OpenAlex
Obesity Hormone Function in Aging Eyes: Linking Adiponectin and its Receptors to AMD (2023)

Preprints.org 1 citation DOI OpenAlex
Wet and Dry Age-Related Macular Degeneration Induced by Polyethylene Glycol (2023)

Preprints.org 3 citations DOI OpenAlex
New Discoveries in Retinal Cell Degeneration and Retinal Diseases (2023)

Biomolecules 3 citations DOI OpenAlex
Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy (2023)

Biomolecules 20 citations DOI OpenAlex
Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration (2022)

Biomolecules 11 citations DOI OpenAlex
Effects of Lidocaine on Mitomycin C Cytotoxicity (2020)

Ophthalmology Glaucoma 4 citations DOI OpenAlex
Role of thalidomide, senicapoc, and sodium butyrate in choroidal neovascularization (2020)

Biochemical and Biophysical Research Communications 7 citations DOI OpenAlex
Protective role of adiponectin against testicular impairment in high-fat diet/streptozotocin-induced type 2 diabetic mice (2019)

Biochimie 61 citations DOI OpenAlex